A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers
Clinical trial NCT05363592 · COMPLETED
Trial details
- NCT number
- NCT05363592
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-25
- Primary completion
- 2022-07-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.